Polysaccharide Polyvalent Pneumococcal Vaccine (Sanofi Pasteur)

23价肺炎球菌多糖疫苗（赛诺菲巴斯德）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePolysaccharide Polyvalent Pneumococcal Vaccine (Sanofi Pasteur)
Drug Alias Name优博23PNEUMO23
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Vaccine type > Multivalent vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsPneumococcal Infections
Approved Indications in ChinaPneumococcal Infections
Original Approved Country/TerritoryCanada
Original Approved Date1997/09/03
Country/TerritoryCanadaThailandMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaWithdrawn
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Pasteur
Active IndicationsN/A
Inactive IndicationsPneumococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A